Immunological mechanisms of vaccination

[1]  C. Bridges,et al.  17 – Inactivated influenza vaccines , 2013 .

[2]  C. Bodemer,et al.  Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity , 2011, Science.

[3]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[4]  R. Ahmed,et al.  Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccines , 2011, Immunology and cell biology.

[5]  S. Manicassamy,et al.  Adenovirus Type 5 Induces Vitamin A–Metabolizing Enzymes in Dendritic Cells and Enhances Priming of Gut Homing CD8 T Cells , 2011, Mucosal Immunology.

[6]  S. Tangye,et al.  Regulation of T follicular helper cell formation and function by antigen presenting cells. , 2011, Current opinion in immunology.

[7]  S. Reed,et al.  Use of defined TLR ligands as adjuvants within human vaccines , 2011, Immunological reviews.

[8]  John Steel,et al.  Programming the magnitude and persistence of antibody responses with innate immunity , 2010, Nature.

[9]  F. Hermann,et al.  Basophils Support the Survival of Plasma Cells in Mice , 2010, The Journal of Immunology.

[10]  Michael Meyer-Hermann,et al.  Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter , 2010, Cell.

[11]  D. Artis,et al.  Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. , 2010, Trends in immunology.

[12]  R. Coffman,et al.  Vaccine adjuvants: putting innate immunity to work. , 2010, Immunity.

[13]  Ronald N Germain,et al.  Vaccines and the future of human immunology. , 2010, Immunity.

[14]  R. Ahmed,et al.  From vaccines to memory and back. , 2010, Immunity.

[15]  Kang Chen,et al.  Vaccination Strategies to Promote Mucosal Antibody Responses , 2010, Immunity.

[16]  A. Casadevall,et al.  A requirement for FcγR in antibody-mediated bacterial toxin neutralization , 2010, The Journal of experimental medicine.

[17]  B. Pulendran,et al.  Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine Vectors , 2010, Journal of Virology.

[18]  S. Halstead,et al.  How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections , 2010, Clinical and Vaccine Immunology.

[19]  H. Hammad,et al.  Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen , 2010, The Journal of experimental medicine.

[20]  D. Voehringer,et al.  Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. , 2010, Immunity.

[21]  B. Pulendran,et al.  Activation of β-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine , 2010, Science.

[22]  Kylie M. Quinn,et al.  CD8+ T Cell Responses following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c+ Dendritic Cells but Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling , 2010, The Journal of Immunology.

[23]  Bali Pulendran,et al.  Programming dendritic cells to induce TH2 and tolerogenic responses , 2010, Nature Immunology.

[24]  T. Kepler,et al.  The T helper type 2 response to cysteine proteases requires dendritic cell–basophil cooperation via ROS-mediated signaling , 2010, Nature Immunology.

[25]  P. Rod Dunbar,et al.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens , 2010, The Journal of experimental medicine.

[26]  Anna M. Keller,et al.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells , 2010, The Journal of experimental medicine.

[27]  R. Rappuoli,et al.  New adjuvants for human vaccines. , 2010, Current opinion in immunology.

[28]  P. Kloetzel,et al.  Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells , 2010, The Journal of experimental medicine.

[29]  G. Carlone,et al.  Advances in the development of vaccines against Neisseria meningitidis. , 2010, The New England journal of medicine.

[30]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[31]  A MarioCalvo,et al.  Vaccination with ALVAC and AIDS-VAX to prevent HIV-1 infection in Thailand , 2010 .

[32]  C. Coban,et al.  Plasmacytoid Dendritic Cells Delineate Immunogenicity of Influenza Vaccine Subtypes , 2010, Science Translational Medicine.

[33]  W. Paul,et al.  Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.

[34]  H. Ueno,et al.  Harnessing human dendritic cell subsets for medicine , 2010, Immunological reviews.

[35]  Michael Gale,et al.  Recognition of viruses by cytoplasmic sensors. , 2010, Current opinion in immunology.

[36]  A. Iwasaki,et al.  Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.

[37]  J. Duncan,et al.  How the Noninflammasome NLRs Function in the Innate Immune System , 2010, Science.

[38]  J. Stockman.  Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease , 2010 .

[39]  A. Telenti,et al.  Critical role for the chemokine receptor CXCR 6 in NK cell – mediated antigen-specific memory of haptens and viruses , 2010 .

[40]  S. Jameson,et al.  Diversity in T cell memory: an embarrassment of riches. , 2009, Immunity.

[41]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[42]  D. Harper.  Currently approved prophylactic HPV vaccines , 2009, Expert review of vaccines.

[43]  W. Heath,et al.  Dendritic cell subsets in primary and secondary T cell responses at body surfaces , 2009, Nature Immunology.

[44]  I. Carletti,et al.  Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years , 2009, Human vaccines.

[45]  Bali Pulendran,et al.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology , 2009, Nature Reviews Immunology.

[46]  Beatrix Grubeck-Loebenstein,et al.  Vaccination in the elderly: an immunological perspective. , 2009, Trends in immunology.

[47]  P. Schneider,et al.  Cracking the BAFF code , 2009, Nature Reviews Immunology.

[48]  S. Gringhuis,et al.  Signalling through C-type lectin receptors: shaping immune responses , 2009, Nature Reviews Immunology.

[49]  Elizabeth E Gray,et al.  The microanatomy of B cell activation. , 2009, Current opinion in immunology.

[50]  B. Pulendran,et al.  TLR2 dependent induction of vitamin A metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits TH-17 mediated autoimmunity , 2009, Nature Medicine.

[51]  Liping Yang,et al.  Cytokine-induced memory-like natural killer cells , 2009, Proceedings of the National Academy of Sciences.

[52]  S. Todryk,et al.  Potency assays for novel T-cell-inducing vaccines against malaria. , 2009, Current opinion in molecular therapeutics.

[53]  M. Iwata.  Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking. , 2009, Seminars in immunology.

[54]  Joseph C. Sun,et al.  Adaptive Immune Features of Natural Killer Cells , 2009, Nature.

[55]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[56]  Bastian R. Angermann,et al.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.

[57]  Mark M Davis,et al.  A prescription for human immunology. , 2008, Immunity.

[58]  R. Glass,et al.  Inactivated rotavirus vaccines: a priority for accelerated vaccine development. , 2008, Vaccine.

[59]  R. Steinman.  Dendritic cells in vivo: a key target for a new vaccine science. , 2008, Immunity.

[60]  H. Ueno,et al.  Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. , 2008, Immunity.

[61]  H. Hammad,et al.  Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome , 2008, The Journal of Immunology.

[62]  Katherine A. Fitzgerald,et al.  Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling , 2008, PLoS pathogens.

[63]  R. Rappuoli,et al.  Molecular and cellular signatures of human vaccine adjuvants , 2008, Proceedings of the National Academy of Sciences.

[64]  D. Monack.  Faculty Opinions recommendation of Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. , 2008 .

[65]  D. Hoft.  Tuberculosis vaccine development: goals, immunological design, and evaluation , 2008, The Lancet.

[66]  F. Re,et al.  Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31 , 2008, The Journal of Immunology.

[67]  Hiroshi Kiyono,et al.  Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5 , 2008, Nature Immunology.

[68]  Richard A. Flavell,et al.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants , 2008, Nature.

[69]  L. Lefrançois,et al.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. , 2008, Immunity.

[70]  M. Irwin,et al.  Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. , 2008, The Journal of infectious diseases.

[71]  A. Arvin.  Humoral and cellular immunity to varicella-zoster virus: an overview. , 2008, The Journal of infectious diseases.

[72]  P. Rangarajan,et al.  Human monoclonal antibody and vaccine approaches to prevent human rabies. , 2008, Current topics in microbiology and immunology.

[73]  S. Plotkin.  Correlates of Vaccine-Induced Immunity , 2008 .

[74]  P. Bousso,et al.  Real-time manipulation of T cell-dendritic cell interactions in vivo reveals the importance of prolonged contacts for CD4+ T cell activation. , 2007, Immunity.

[75]  Shohei Koyama,et al.  Differential Role of TLR- and RLR-Signaling in the Immune Responses to Influenza A Virus Infection and Vaccination , 2007, The Journal of Immunology.

[76]  B. Pulendran,et al.  Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17–producing T cell responses , 2007, Nature Immunology.

[77]  E. Wherry,et al.  Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. , 2007, Immunity.

[78]  Y. Belkaid,et al.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid , 2007, The Journal of experimental medicine.

[79]  Y. Belkaid,et al.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.

[80]  J. Harty,et al.  Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. , 2007, Immunity.

[81]  Thomas C. Mitchell,et al.  The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.

[82]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[83]  R. Steinman,et al.  A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo , 2007, The Journal of experimental medicine.

[84]  Ofer Levy,et al.  Innate immunity of the newborn: basic mechanisms and clinical correlates , 2007, Nature Reviews Immunology.

[85]  R. Steinman,et al.  Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.

[86]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[87]  B. Beutler,et al.  Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling , 2006, Science.

[88]  Ronald N Germain,et al.  Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. , 2006, Immunity.

[89]  Brigitte Colau,et al.  Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only. , 2006, Vaccine.

[90]  Grégoire Altan-Bonnet,et al.  Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction , 2006, Nature.

[91]  Bali Pulendran,et al.  Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.

[92]  Bali Pulendran,et al.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity , 2006, The Journal of experimental medicine.

[93]  Sandra Romero-Steiner,et al.  Use of Opsonophagocytosis for Serological Evaluation of Pneumococcal Vaccines , 2006, Clinical and Vaccine Immunology.

[94]  T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly , 2006 .

[95]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[96]  Francesco Bertoni,et al.  Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells , 2005, Nature Immunology.

[97]  C. Goodnow,et al.  Cellular and genetic mechanisms of self tolerance and autoimmunity , 2005, Nature.

[98]  R. Hetzer,et al.  Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells , 2005, The Journal of experimental medicine.

[99]  L. McHeyzer-Williams,et al.  Antigen-specific memory B cell development. , 2005, Annual review of immunology.

[100]  Randall L. Lindquist,et al.  Visualizing dendritic cell networks in vivo , 2004, Nature Immunology.

[101]  R. Koup,et al.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know , 2004, Nature Medicine.

[102]  P. Marrack,et al.  Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population , 2004, Science.

[103]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[104]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[105]  T. Mueller,et al.  Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation1 , 2003, The Journal of Immunology.

[106]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[107]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[108]  Philippe Bousso,et al.  Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes , 2003, Nature Immunology.

[109]  A. Prentice,et al.  Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children , 2003, Acta paediatrica.

[110]  Ruslan Medzhitov,et al.  Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.

[111]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[112]  R. Germain,et al.  Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph Nodes , 2002, Science.

[113]  Mark J. Miller,et al.  Two-Photon Imaging of Lymphocyte Motility and Antigen Response in Intact Lymph Node , 2002, Science.

[114]  Rustom Antia,et al.  Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.

[115]  C. Bogdan,et al.  Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity , 2002, The Journal of experimental medicine.

[116]  A. Meyerhans,et al.  LEVELS OF VIRUS-SPECIFIC CD4 T CELLS CORRELATE WITH CYTOMEGALOVIRUS CONTROL AND PREDICT VIRUS-INDUCED DISEASE AFTER RENAL TRANSPLANTATION1 , 2001, Transplantation.

[117]  A. Iwasaki,et al.  Unique Functions of CD11b+, CD8α+, and Double-Negative Peyer’s Patch Dendritic Cells1 , 2001, The Journal of Immunology.

[118]  C. Stephensen.  Vitamin A, infection, and immune function. , 2001, Annual review of nutrition.

[119]  M. Bevan,et al.  Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.

[120]  Federica Sallusto,et al.  Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production , 2000, The Journal of experimental medicine.

[121]  P. Loetscher,et al.  Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.

[122]  Osamu Takeuchi,et al.  Maturation of Human Dendritic Cells by Cell Wall Skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: Involvement of Toll-Like Receptors , 2000, Infection and Immunity.

[123]  A E Fiore,et al.  Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[124]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[125]  J. Lang,et al.  Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. , 1999, The American journal of tropical medicine and hygiene.

[126]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[127]  B. Pulendran,et al.  Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[128]  H. Whittle,et al.  What level of hepatitis B antibody is protective? , 1999, The Journal of infectious diseases.

[129]  R. Maldonado-López,et al.  CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo , 1999, The Journal of experimental medicine.

[130]  P. Densen,et al.  Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. , 1993, The Journal of infectious diseases.

[131]  Rolf M. Zinkernagel,et al.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells , 1993, Nature.

[132]  R M Pitkin,et al.  An embarrassment of riches. , 1989, Obstetrics and gynecology.

[133]  H. S. Kaye,et al.  Inactivated vaccines. 2. Laboratory indices of protection* , 1973 .

[134]  H. S. Kaye,et al.  Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation* , 1973, Postgraduate medical journal.

[135]  H. S. Kaye,et al.  Inactivated influenza vaccines. 2. Laboratory indices of protection. , 1973, Postgraduate medical journal.

[136]  F. Bang,et al.  Lymphocyte depression induced in chickens on diets deficient in vitamin A and other components. , 1972, The American journal of pathology.

[137]  Wheelock Ef,et al.  CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. , 1965 .

[138]  W. Sibley,et al.  CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. , 1965, The New England journal of medicine.

[139]  G. Edsall,et al.  Persistence of antitoxin levels after tetanus-toxoid inoculation in adults, and effect of a booster dose after various intervals. , 1956, The New England journal of medicine.

[140]  J. Ipsen,et al.  Circulating antitoxin at the onset of diphtheria in 425 patients. , 1946, Journal of immunology.